Literature DB >> 22498732

Pleural effusion in pulmonary embolism.

Serhat Findik1.   

Abstract

PURPOSE OF REVIEW: Pulmonary embolism is a common and potentially lethal disease that recurs frequently and is associated with long-term impairment and suffering. Patients with pulmonary embolism are at risk of death, recurrence of embolism, or chronic morbidity. Appropriate therapy can reduce the incidence of all. Pulmonary embolism is the most commonly overlooked disorder in patients with pleural effusion. Recent findings of pleural effusions due to pulmonary embolism are discussed in this review. RECENT
FINDINGS: The presence of pleuritic chest pain in a patient with a pleural effusion is highly suggestive of pulmonary embolism. Nearly all pleural effusions due to pulmonary embolism are exudates, frequently hemorrhagic, and with a marked mesothelial hyperplasia. Patients with a pleural effusion are likely to have an embolus in the central, lobar, segmental, or subsegmental pulmonary arteries and these are the regions in which spiral computed tomography pulmonary angiography (CTPA) can detect an embolus. No specific treatment is required for pleural effusion. The presence of bloody pleural fluid is not a contraindication for the administration of anticoagulant therapy.
SUMMARY: Pulmonary embolism is probably responsible for a significant percentage of undiagnosed exudative pleural effusions. Spiral CTPA is the best way to evaluate the possibility of pulmonary embolism in a patient with a pleural effusion. The treatment protocol of the patient with pleural effusion secondary to pulmonary embolism is the same as that for any patient with pulmonary embolism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22498732     DOI: 10.1097/MCP.0b013e32835395d5

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  4 in total

1.  Pleural effusions as a predictive parameter for poor prognosis for patients with acute pulmonary thromboembolism.

Authors:  Xia Zhou; Zhu Zhang; Zhenguo Zhai; Yunxia Zhang; Ran Miao; Yuanhua Yang; Wanmu Xie; Jun Wan; Chen Wang
Journal:  J Thromb Thrombolysis       Date:  2016-10       Impact factor: 2.300

Review 2.  Antiplatelet Therapy in Acute Coronary Syndrome.

Authors:  Kerry Layne; Albert Ferro
Journal:  Eur Cardiol       Date:  2017-08

3.  Incidence of pleural effusion in patients with pulmonary embolism.

Authors:  Min Liu; Ai Cui; Zhen-Guo Zhai; Xiao-Juan Guo; Man Li; Lei-Lei Teng; Li-Li Xu; Xiao-Juan Wang; Zhen Wang; Huan-Zhong Shi
Journal:  Chin Med J (Engl)       Date:  2015-04-20       Impact factor: 2.628

4.  Dynamics of CT visible pleural effusion in patients with pulmonary infarction.

Authors:  Igor Kocijancic; Jernej Vidmar; Marko Kastelic
Journal:  Radiol Oncol       Date:  2018-09-11       Impact factor: 2.991

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.